Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.

Annual average cost of orphan drugs per patient 2014-2018

Average annual cost of orphan drugs per patient from 2014 to 2018 (in U.S. dollars)*

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2019

Region

United States

Survey time period

2014 to 2018

Supplementary notes

* Including the top 100 products.
* Products that have orphan and non-orphan drug designations and are expected to generate less than 50% of their sales in 2018 and 2024 from their orphan-designated indication/s, are excluded from this statistic. This has led to the exclusion of therapies such as Avastin, Opdivo, Enbrel, Herceptin, Humira and Remicade.

Open this statistic in...
Citation formats
Use Statista now: Unlimited Access to All Statistics! $199 USD / Month
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry

9

About the region

10

Selected statistics

6

Other regions

10

Related statistics

10

Further related statistics

9
All features, all contents, at all times: Learn more about our professional solutions.
Learn more about how Statista can support your business.